Board & Advisors
Kismet Technologies partners with world-class strategic and scientific advisors to support our cutting-edge technologies.
Mark Montgomery has scaled and successfully exited several multi-billion dollar specialty pharmacy organizations. He joined as the CEO of BioPlus Specialty Pharmacy in 2018. Over four years, he secured private equity and orchestrated substantial growth, catapulting the company’s annual revenue to over $2 billion by 2022. Bioplus was successfully acquired by Elevance, formerly known as Anthem Health, a Fortune 20 company. Prior to that Mark held many leadership positions in his illustrious career. He CEO of Axium Healthcare from 2006 and guiding the company to a lucrative acquisition by Kroger in 2012. This acquisition marked the inception of Kroger Specialty Pharmacy, which has since flourished into a thriving entity with an annual revenue surpassing $5 billion. He has actively served on the boards of Axium, Panacea BioMatrix, Avant Healthcare Professionals, and Bioplus. Notably, he also contributed his expertise as a board member of PromptCare during his esteemed career.
Mark Montgomery
CEO, BioPlus Specialty Pharmacy
Board Member
Patty Olinger, a distinguished leader in public health, with a focus on wellness and public health preparedness. She currently holds the position of Founder and CEO at BEAMS LLC Consulting. By meticulously crafting targeted business development strategies and targets, Patty provides coaching, connections and consulting services that empowers organizations to expand their reach to achieve meaningful goals. Patty also serves on key Advisor Boards to pioneering biotech companies that are dedicated to delivering innovative solutions in the realms of health, wellness, and resilience programs.
Patricia Olinger, JM
CEO Beams, LLC
Strategic Advisor
Orlando Ashford is the Chief People Officer at Fanatics. He previously served as president of Holland America Line. Orlando was selected by Seattle Business Magazine for the 2019 Executive Excellence Award, honoring the best-of-the-best leaders in Washington state business and community. In 2017, Black Enterprise Magazine named Orlando to their 2017 list of the “Most Powerful Executives in Corporate America,” and in 2016 he was awarded a Travvy Award for “Most Innovative Executive, Mid-sized Cruise.” He serves on numerous boards, including the Chairman of Perrigo Company plc, the director for Azamara, Array Technologies, Inc., and Hersey Entertainment and Resorts (previous).
Orlando Ashford
Chief People Officer, Fanatics
Strategic Advisor
Dan Justin has over 30 years of experience engineering orthopedic medical implant systems. He is a serial entrepreneur with successful to companies such a Smith and Nephew Orthopedics. Dan has developed over 110 other medical device systems used clinically worldwide, including implant systems in the areas of knee, hip, and shoulder arthroplasty, sports medicine arthroscopy, spinal implants, foot and ankle implants, bone lengthening, and orthopedic trauma implants. He has published 40 national and international papers. He is the CEO of Nanovation Partners and Chairman of Genesis New Ventures. start-up companies.
Dan Justin
Chairman, Exodus New Ventures
Strategic Advisor
Dr. Sudipta Seal is a world-renowned expert on rare earth/lanthanide metal oxide nanoparticles manufacturing for various biomedical applications. Dr. Seal is the Chair of the Materials Science & Engineering Department, a Pegasus Professor and University Distinguished Professor.
Dr. Sudipta Seal
Scientific Advisor
Dr. Griffith Parks is an internationally recognized expert in the molecular and cellular biology of RNA viruses, with more than 30 years of experience researching human pathogenic viruses such as poliovirus, influenza virus, parainfluenza virus, and Zika virus. He is Associate Dean for Research in the College of Medicine at UCF, Director of the Biomedical Sciences Graduate Program, Director of the Burnett School of Biomedical Sciences and Professor of Medicine.
Dr. Griffith Parks
Scientific Advisor
Dr. Melanie Coathup is Director of the Biionix Cluster at UCF, and her research focuses on translational innovation and the development of therapies and technologies that deliver improved patient care. Her research has led to a novel implant design being used in patients worldwide, and a novel biostimulative scaffold developed for accelerated bone repair, now marketed by Baxter Healthcare, and used in spinal fusion surgery.
Dr. Melanie Coathup
Scientific Advisor